http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103906752-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_96ec3985e3ce9b24614fb87bf51a4f12
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00
filingDate 2012-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f8eb9083a760f715a6fc9f2103e5e3c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1cf9ffad63310e09d9c13acdf43cae49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bdc162c88345e2f2f04e5f99a5bd474
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9098f175c5af0be15454efd460751da0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_524c8503be65afb2d3b517ccd87b4770
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35a3ef3494bc6a8c2d5d2531f338eba0
publicationDate 2014-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103906752-A
titleOfInvention Heteroaryl-substituted pyrazolopyridines and their use as stimulators of soluble guanylate cyclase
abstract The present invention relates to novel heteroaryl-substituted pyrazolopyridines, to processes for their preparation, to their use alone or in combination for the treatment and/or prophylaxis of diseases, and to their use in the preparation of therapeutic and/or prophylactic Diseases - especially the use of medicinal products for the prevention and/or treatment of cardiovascular conditions.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023061432-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021219088-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106560180-A
priorityDate 2011-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010065275-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03095451-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011149921-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9816507-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6903089-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419839801
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66614055
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466546885
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71503128
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420880842
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136226896
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90330466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID146829949
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407167052
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467984785
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71488248
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163949661
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421485788
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421843632
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90330624
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413663619
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465717543
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419839836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467011415
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466419987

Total number of triples: 56.